InMed CEO Eric A. Adams will join Water Tower Research in this Fireside Chat.
Date: January 25, 2024
Time: 1:00pm ET
Interested parties can register for the event here. Replays of the webcast will also be available after the event.
In this fireside chat, CEO Eric A. Adams will provide an update on our pharmaceutical programs and upcoming milestones. This event is open access for all investors. Topics will include:
- An overview of InMed’s pharmaceutical pipeline in Alzheimer’s and Age-related Macular Degeneration (“AMD”)
- A discussion of upcoming 2024 milestones in both InMed’s pharmaceutical drug development and in BayMedica’s health and wellness initiatives
- An overview of cannabinoids and their possible role in the treatment of Alzheimer’s
